In patients with cirrhosis, the use of albumin prevents circulatory dysfunction after paracentesis, improves the outcomes in patients with refractory ascites, spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome (HRS) [2, 3]. The gene discussed is ALB; the disease is Cirrhosis.